(Q44787827)

6 December 2017

title

JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. (English)

1 reference

6 December 2017

Jen-Chine Wu

1

1 reference

6 December 2017

Horng-Chin Yan

2

1 reference

6 December 2017

Wei-Teing Chen

3

1 reference

6 December 2017

Wei-Hwa Chen

4

1 reference

6 December 2017

Chia-Jen Wang

5

1 reference

6 December 2017

Ying-Chih Chi

6

1 reference

6 December 2017

Woei-Yau Kao

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

6 October 2007

1 reference

Experimental Cell Research

6 December 2017

published in

1 reference

6 December 2017

volume

314

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

421-429

1 reference

VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Molecular mechanisms that control endothelial cell contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Cytoskeletal regulation of pulmonary vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Structural and functional diversity of cadherin superfamily: are new members of cadherin superfamily involved in signal transduction pathway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Regulation of endothelial cell contacts during leukocyte extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Rate of endothelial expansion is controlled by cell:cell adhesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Molecular mechanisms of tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Signaling by fibroblast growth factors: the inside story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Angiogenesis and signal transduction in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Promotion and attenuation of FGF signaling through the Ras-MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Activated Ras induces a proangiogenic phenotype in primary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Endothelial cadherins and tumor angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Endothelial-pericyte interactions in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Endothelial cell-cell junctions: happy together

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Fibroblast growth factor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Murine FGFR-1 is required for early postimplantation growth and axial organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Regulation of vascular development by fibroblast growth factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

c-Jun N-terminal kinase is involved in motility of endothelial cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

H-Ras is a negative regulator of alpha3beta1 integrin expression in ECV304 endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Protecting your tail: regulation of cadherin degradation by p120-catenin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: association with replicative life span

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.10.002

10.1016/J.YEXCR.2007.10.002

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference